(Q78365393)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377327%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

title

Prognostic value of Chinese race in nasopharyngeal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377327%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

author name string

Catherine K Su

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377327%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

C C Wang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377327%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

language of work or name

English

0 references

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377327%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

13 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377327%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377327%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377327%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

page(s)

752-758

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377327%20AND%20SRC:MED&resulttype=core&format=json

Risk factors associated with nasopharyngeal carcinoma

13 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

The role of chemotherapy in the management of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: toxicities and preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Nasopharyngeal carcinoma: orderly neck node spread

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

The prognostic significance of parapharyngeal tumour involvement in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Histopathology of nasopharyngeal carcinoma.Correlations with epidemiology, survival rates and other biological characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Techniques and results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progr

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal ca

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Carcinoma of the nasopharynx—The significance of histology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902969-3

7 January 2021

10.1016/S0360-3016(02)02969-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12377327%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

1 reference